Test Price
2,800 AED✅ Home Collection Available
XPNPEP3 Gene Nephronophthisis-Like Nephropathy Type 1 Genetic Test
Executive Summary & Core Metrics
The XPNPEP3 Genetic Test is a definitive molecular diagnostic assay employing Next Generation Sequencing (NGS) to analyze the entire coding region of the XPNPEP3 gene. This test identifies pathogenic variants causative of nephronophthisis-like nephropathy type 1 (NPHPL1), a rare autosomal recessive ciliopathy affecting renal tubular function, hepatic integrity, and endocrine homeostasis. The assay delivers 99.9% diagnostic sensitivity through ISO 9001:2015 accredited processing (Cert: INT/EGQ/2509DA/3139). Premium logistics include VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM across all seven emirates. Post-test telephonic clinical guidance in result interpretation is provided by qualified genetic counsellors. Direct billing verification is available via WhatsApp at +971 54 548 8731.
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing (Cert: INT/EGQ/2509DA/3139).
- ✓ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM – 11 PM daily).
- ✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by qualified genetic counsellors.
- ✓ Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The XPNPEP3 Genetic Test utilizes Next Generation Sequencing (NGS) with comprehensive coverage of all coding exons and intron-exon boundaries, including copy number variation (CNV) analysis. This methodology provides superior diagnostic yield compared to conventional Sanger sequencing, which typically targets single exons only and may miss larger structural rearrangements. The assay is performed on high-quality extracted DNA from peripheral whole blood or FTA card dried blood spots, ensuring robust and reproducible results across all submitted specimens.
| Feature | Our Test (DHA-Licensed) | Closest Alternative |
|---|---|---|
| Precision / Methodology | NGS (Next Generation Sequencing) – Full gene coverage with CNV analysis | Sanger sequencing (single-exon only) or panel-based limited coverage |
| Turnaround Speed | 3 to 4 Weeks (ISO Cold-Chain Expedited) | 6 to 10 Weeks (standard commercial labs) |
| Regulatory Compliance | DHA/MOHAP Licensed, ISO 9001:2015, UAE PDPL Compliant | Variable; often lacks UAE-specific data privacy certification |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403) – "A positive XPNPEP3 genetic result provides critical diagnostic clarity for nephronophthisis-like nephropathy type 1; however, it must always be correlated with renal ultrasound findings, liver function panels, and urine concentrating capacity tests. A negative result does not exclude all forms of nephronophthisis, and clinical vigilance with serial monitoring remains essential. Every patient deserves compassionate counseling and a multidisciplinary care plan tailored to their unique genetic profile."
⚠ Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. Genetic test results are one component of a comprehensive clinical assessment and must never be used in isolation to alter therapeutic regimens. Always discuss any changes to your treatment plan with a qualified healthcare professional.
🛑 Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: This test is not indicated for acute renal failure diagnosis; it is a germline genetic test for hereditary nephropathy risk assessment only.
- Exclusion: Patients under 18 years require documented informed consent from a legal guardian in strict compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- ER Red Flag: If the patient experiences sudden oliguria, anuria, severe flank pain, or hypertensive crisis, proceed immediately to the nearest emergency department — do not await genetic test results.
- ER Red Flag: New-onset hepatic encephalopathy or severe electrolyte disturbances warrant urgent hospitalization irrespective of XPNPEP3 status.
Patient FAQ & Clinical Guidance
1. What does the XPNPEP3 Genetic Test actually detect, and how reliable is it?
This test sequences the entire XPNPEP3 gene using Next Generation Sequencing to detect pathogenic single nucleotide variants, small insertions/deletions, and copy number variations with 99.9% diagnostic sensitivity when performed on high-quality extracted DNA from whole blood or FTA card samples. Results are interpreted by board-certified molecular geneticists and reported with clear variant classifications according to ACMG guidelines.
2. What sample types are accepted, and how is the collection performed in the UAE?
We accept whole blood (venipuncture), extracted DNA, or dried blood spot on an FTA card — all collected via our ISO-certified cold-chain home collection service available from 8 AM to 11 PM across all seven emirates. Our trained phlebotomists follow strict infection control protocols and maintain sample integrity throughout the transport chain.
3. Why is pre-test genetic counselling mandatory before ordering this test?
Pre-test genetic counselling is mandatory to construct a detailed three-generation pedigree chart identifying affected family members, to assess autosomal recessive inheritance patterns, and to ensure fully informed consent under Federal Decree-Law No. 4 of 2016 on Medical Liability. This consultation also prepares patients for possible secondary findings and discusses reproductive implications.
4. How long does it take to receive results, and how will they be delivered?
The standard turnaround time is 3 to 4 weeks from sample receipt in our laboratory. Results are delivered electronically via a secure patient portal and are also discussed during a telephonic post-test counselling session with a qualified genetic counsellor who will explain the clinical implications and coordinate any necessary follow-up care.
UAE Regulatory & Data Privacy Adherence
This service adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genomic data is stored and processed exclusively within UAE-sovereign servers with encryption at rest and in transit. Our laboratory operates under DHA Facility License Number 1143 and maintains ISO 9001:2015 Quality Management System certification (Certificate: INT/EGQ/2509DA/3139).
Patient data access is strictly role-based and audited quarterly. No genetic information is shared with third parties without explicit written consent from the patient or legal guardian, as mandated by UAE federal law.
Clinical & Logistical Metadata
| Test Name | XPNPEP3 Gene Nephronophthisis-Like Nephropathy Type 1 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or FTA Card Dried Blood Spot |
| Methodology Used | Next Generation Sequencing (NGS) with CNV Analysis |
| ICD-10-CM Code | Q61.5 |
| LOINC Code | 79241-2 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
📞 Book Your Genetic Counselling & Home Collection
+971 54 548 8731
WhatsApp Support Available | 8 AM – 11 PM UAE Time
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians